Advances in chemoradiation therapy in rectal cancer: The impact of imaging

British Journal of Radiology

Volumn 78, Issue SPEC. ISS. 2, 2005, Pages

  Tait, D ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EXCISION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RECTUM CANCER; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 29644436245     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/22543935     Document Type: Article

References (23)

1. Chawla AK, Kachnic LA, Clark JW, Willett CG. Combined modality therapy for rectal and colon cancer. Semin Oncol 2003;30(4 Suppl. 9):101-12.
2. Farourk R, Nelson H, Cunderson LL. Aggressive multimodality treatment for locally advanced irresectable rectal cancer. Br J Surg 1997;84:741-9.
3. Shibata D, Guillem JG, Lanouette N, Paty P, Minsky B, Harrison L, et al. Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy and sphincter preservation. Dis Colon Rectum 2000;43:752-8.
4. Nordlinger B, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996;77:1254-62.
5. Kemeny MM, et al. Results of the Intergroup (Eastern Cooperative Oncology Group [ECOG] and Southwest Oncology Group [SWOG]). Prospective randomised study of surgery alone versus continuous hepatic artery infusion of FUDR and continuous systemic infusion of 5-FU after hepatic resection for colorectal liver metastases. Proc Am Soc Clin Oncol 1999;18:264a(1012).
6. Okumura S, Kondo H, Tsubio M, Nakayama H, Asamura H, Tsuchiya R, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 1996;112:867-74.
7. Watanabe I, Arai T, Ono M, Sugito M, Kawashima K, Ito M, et al. Prognostic factors in resection of pulmonary metastasis from colorectal cancer. Br J Surg 2003;90:1436-40.
8. Chau I, Allen M, Cunningham D, Tait D, Brown G, Hill M, et al. Neoadjuvant systemic fluorouracil and mitomycin D prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer. Br J Cancer 2003;88:1017-24.
9. Chau I, Cunningham D, Tait D, Brown G, Tebbutt N, Hill M, et al. Twelve weeks of neoadjuvant Capecitabine (cap) and Oxaliplatin (ox) followed by synchronous chemoradiation (CRT) and total mesorectal excision (TME) in MRI defined poor risk locally advanced rectal cancer resulted in promising tumour regession and rapid symptomatic relief. Abstract 1087, ASCO 2003 Annual Meeting. Clin Oncol 2003;22: 271.
10. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-7.
11. Kapiteijn E, Corrie AM, Marijnen MD, Iris D, Nagetgaal MD, Putter H, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.
12. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479-82.
13. Wibe A, Moller B, Norstein J, Carlsen E, Wiig JN, Heald R, et al. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002;45:857-66.
14. Burton S, Daniels I, Brown G, Sellakis M, Chau I, Swift R, et al. Evaluation of the role of MRI in staging rectal cancer within the multidisciplinary team setting. Abstract No: 3611; ASCO Annual Meeting, 2004.
15. Koczwara B, Tie M, Esterman A. Are radiologists meeting the needs of Australian medical oncologists? Results of a national survey. Australas Radiol 2003;47:268-73.
16. WHO Handbook for reporting results of cancer, World Health Organisation 1979:48.
17. James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, et al. Measuring response in solid tumours: unidimensional versus bidimensional measurement. J Natl Cancer Inst 1999;91:523-8.
18. Padhani AR, Ollivier L. The RECIST criteria: implications for diagnostic radiologists. Br J Radiol 2001;74:983-6.
19. Sohaib SA, Turner B, Hanson JA, Farquharson M, Oliver RT, Reznek RH. CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol 2000;73: 1178-84.
20. Prasad SR, Saini S, Liu EW, Sumner JE. Radiology in oncology trials: Critical success factors. Applied Clin Trials 2002.
21. Einat ES, Yoav P, Hedva L, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004;232:815-22.
22. Heald B. Surgical management of rectal cancer: a multidisicplinary approach to technical and technological advaces. Br J Radiol 2005;78(Spec.2):128-30.
23. Chau I, Allen MJ, Cunningham D, Norman AR, Brown G, Hugo ER, et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004;22:1420-9.